Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(4.58)
# 222
Out of 5,165 analysts
76
Total ratings
50.67%
Success rate
44.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AURA Aura Biosciences | Assumes: Buy | $22 | $6.74 | +226.41% | 1 | May 28, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $10 | $2.71 | +269.00% | 1 | May 15, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Buy | $50 → $40 | $9.51 | +320.61% | 2 | May 7, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $15 → $10 | $1.06 | +843.40% | 1 | May 7, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $13.51 | -55.59% | 10 | Apr 30, 2025 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $13 | $4.97 | +161.57% | 1 | Apr 30, 2025 | |
| STRO Sutro Biopharma | Reiterates: Neutral | $20 | $23.49 | -14.86% | 1 | Apr 29, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $5.42 | +324.35% | 1 | Apr 28, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $65.90 | +13.81% | 13 | Apr 28, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $36 | $21.36 | +68.54% | 14 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.81 | +1,749.57% | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $7.23 | +245.78% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $50 | $40.26 | +24.19% | 13 | Nov 26, 2024 |
Aura Biosciences
May 28, 2025
Assumes: Buy
Price Target: $22
Current: $6.74
Upside: +226.41%
Zentalis Pharmaceuticals
May 15, 2025
Reiterates: Buy
Price Target: $10
Current: $2.71
Upside: +269.00%
Corbus Pharmaceuticals Holdings
May 7, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $9.51
Upside: +320.61%
TScan Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $1.06
Upside: +843.40%
Erasca
Apr 30, 2025
Reiterates: Buy
Price Target: $6
Current: $13.51
Upside: -55.59%
Foghorn Therapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $13
Current: $4.97
Upside: +161.57%
Sutro Biopharma
Apr 29, 2025
Reiterates: Neutral
Price Target: $20
Current: $23.49
Upside: -14.86%
Protara Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $23
Current: $5.42
Upside: +324.35%
CG Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $75
Current: $65.90
Upside: +13.81%
Day One Biopharmaceuticals
Apr 3, 2025
Reiterates: Buy
Price Target: $36
Current: $21.36
Upside: +68.54%
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $0.81
Upside: +1,749.57%
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $7.23
Upside: +245.78%
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $40.26
Upside: +24.19%